Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial

Metformin therapy associated with survival benefit in lung cancer patients with diabetes

(2016) Guoxing Wan et al.   Oncotarget

Survival of Patients with Stage IV Lung Cancer with Diabetes Treated with Metformin

(2015) Jenny J. Lin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes

(2015) Hengyi Chen et al.   CANCER LETTERS

LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

(2013) David B. Shackelford et al.   CANCER CELL

PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2013) Luis G. Paz-Ares et al.   JOURNAL OF CLINICAL ONCOLOGY

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

(2013) Christian Boch et al.   BMJ Open

Metformin intake is associated with better survival in ovarian cancer

(2012) Sanjeev Kumar et al.   CANCER

Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

(2011) Ben-Xu Tan et al.   CANCER

The Effect of Metformin and Thiazolidinedione Use on Lung Cancer

(2011) Peter J. Mazzone et al.   CHEST

Metformin and neoplasia: Implications and indications

(2011) Ahmad Aljada et al.   PHARMACOLOGY & THERAPEUTICS

Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis

(2010) R. M. Memmott et al.   Cancer Prevention Research

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

(2009) Sao Jiralerspong et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Somatic mutations affect key pathways in lung adenocarcinoma

(2008) Li Ding et al.   NATURE